Subscribe

Interview with the Innovators: Current Approach to the Disease Journey of Patients with Relapsed or Refractory Follicular Lymphoma:

Current Approach to the Disease Journey of Patients with Relapsed or Refractory Follicular Lymphoma: Focus on the Key Manifestations, Risk Stratification, and Management Patterns

Supported through funding from

Current Approach to the Disease Journey of Patients with Relapsed or Refractory Follicular Lymphoma: Focus on the Key Manifestations, Risk Stratification, and Management Patterns
Current Approach to the Disease Journey of Patients with Relapsed or Refractory Follicular Lymphoma: Focus on the Key Manifestations, Risk Stratification, and Management Patterns
By Tycel J. Phillips, MD; Peg Rummel, MHA, RN, OCN, NE-BC; Andrew D. Zelenetz, MD, PhD
Interview with the Innovators: Current Approach to the Disease Journey of Patients with Relapsed or Refractory Follicular Lymphoma:
Follicular lymphoma (FL) is a low-grade type of B-cell non-Hodgkin lymphoma (NHL) and the second most common malignancy within NHLs.1,2
Read More


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

© Amplity Health. All Rights Reserved. Privacy Policy.